Allogeneic extracellular secretomes (EVs) derived from umbilical cord mesenchymal stromal cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic extracellular secretomes (EVs) derived from umbilical cord mesenchymal stromal cells, covering 2025-04-30 to 2025-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial. [Phase 1]